When the “old” classification was used, the expression of CRNDE, FREM2, and SPRY genes allowed the diagnosis of “glioblastoma, grade IV” to be differentiated from the lower grade gliomas (astrocytomas, oligoastrocytomas, and oligodendrogliomas). The gene discussed is CRNDE; the disease is central nervous system cancer.